Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2018

Open Access 01-12-2018 | Research article

Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments

Authors: Mathieu van Steenberghe, Thomas Schubert, Sébastien Gerelli, Caroline Bouzin, Yves Guiot, Daela Xhema, Xavier Bollen, Karim Abdelhamid, Pierre Gianello

Published in: Journal of Cardiothoracic Surgery | Issue 1/2018

Login to get access

Abstract

Background

Glutaraldehyde fixed xenogeneic heart valve prosthesis are hindered by calcification and lack of growth potential. The aim of tissue decellularization is to remove tissue antigenicity, avoiding the use of glutaraldehyde and improve valve integration with low inflammation and host cell recolonization. In this preliminary study, we investigated the efficacy of a NaOH-based process for decellularization and biocompatibility improvement of porcine pulmonary heart valves in comparison to a detergent-based process (SDS-SDC0, 5%).

Methods

Native cryopreserved porcine pulmonary heart valves were treated with detergent and NaOH-based processes.
Decellularization was assessed by Hematoxylin and eosin/DAPI/alpha-gal/SLA-I staining and DNA quantification of native and processed leaflets, walls and muscles.
Elongation stress test investigated mechanical integrity of leaflets and walls (n = 3 tests/valve component) of valves in the native and treated groups (n = 4/group).
Biochemical integrity (collagen/elastin/glycosaminoglycans content) of leaflet-wall and muscle of the valves (n = 4/group) was assessed and compared between groups with trichrome staining (Sirius Red/Miller/Alcian blue).
Secondly, a preliminary in vivo study assessed biocompatibility (CD3 and CD68 immunostaining) and remodeling (Hematoxylin and eosin/CD31 and ASMA immunofluorescent staining) of NaOH processed valves implanted in orthotopic position in young Landrace pigs, at 1 (n = 1) and 3 months (n = 2).

Results

Decellularization was better achieved with the NaOH-based process (92% vs 69% DNA reduction in the wall). Both treatments did not significantly alter mechanical properties. The detergent-based process induced a significant loss of glycosaminoglycans (p < 0,05).
In vivo, explanted valves exhibited normal morphology without any sign of graft dilatation, degeneration or rejection. Low inflammation was noticed at one and three months follow-up (1,8 +/− 3,03 and 0,9836 +/− 1,3605 CD3 cells/0,12 mm2 in the leaflets). In one animal, at three months we documented minimal calcification in the area of sinus leaflet and in one, microthrombi formation on the leaflet surface at 1 month. The endoluminal side of the valves showed partial reendothelialization.

Conclusions

NaOH-based process offers better porcine pulmonary valve decellularization than the detergent process. In vivo, the NaOH processed valves showed low inflammatory response at 3 months and partial recellularization. Regarding additional property of securing, this treatment should be considered for the new generation of heart valves prosthesis.

Graphical abstract

Graphical abstract of the study
Literature
1.
go back to reference Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072–80.CrossRefPubMed Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072–80.CrossRefPubMed
2.
go back to reference Umashankar PR, Mohanan PV, Kumari TV. Glutaraldehyde treatment elicits toxic response compared to decellularization in bovine pericardium. Toxicol Int. 2012;19:51–8.CrossRefPubMedPubMedCentral Umashankar PR, Mohanan PV, Kumari TV. Glutaraldehyde treatment elicits toxic response compared to decellularization in bovine pericardium. Toxicol Int. 2012;19:51–8.CrossRefPubMedPubMedCentral
3.
go back to reference Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114:318–27.CrossRefPubMed Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA, Rajotte RV, Koshal A, Ross DB. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation. 2006;114:318–27.CrossRefPubMed
4.
go back to reference Choi SY, Jeong HJ, Lim HG, Park SS, Kim SH, Kim YJ. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. J Heart Valve Dis. 2012;21:387–97.PubMed Choi SY, Jeong HJ, Lim HG, Park SS, Kim SH, Kim YJ. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves. J Heart Valve Dis. 2012;21:387–97.PubMed
5.
go back to reference Hu XJ, Dong NG, Shi JW, Deng C, Li HD, Lu CF. Evaluation of a novel tetra-functional branched poly(ethylene glycol) crosslinker for manufacture of crosslinked, decellularized, porcine aortic valve leaflets. J Biomed Mater Res B Appl Biomater. 2014;102:322–36.CrossRefPubMed Hu XJ, Dong NG, Shi JW, Deng C, Li HD, Lu CF. Evaluation of a novel tetra-functional branched poly(ethylene glycol) crosslinker for manufacture of crosslinked, decellularized, porcine aortic valve leaflets. J Biomed Mater Res B Appl Biomater. 2014;102:322–36.CrossRefPubMed
6.
go back to reference Dohmen PM. Clinical results of implanted tissue engineered heart valves. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4:225–31.PubMedPubMedCentral Dohmen PM. Clinical results of implanted tissue engineered heart valves. HSR Proc Intensive Care Cardiovasc Anesth. 2012;4:225–31.PubMedPubMedCentral
7.
go back to reference Shaddy RE, Hawkins JA. Immunology and failure of valved allografts in children. Ann Thorac Surg. 2002;74:1271–5.CrossRefPubMed Shaddy RE, Hawkins JA. Immunology and failure of valved allografts in children. Ann Thorac Surg. 2002;74:1271–5.CrossRefPubMed
8.
go back to reference Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg. 1969;58:467–83.PubMed Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg. 1969;58:467–83.PubMed
9.
go back to reference Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111–7.CrossRefPubMed Rajani B, Mee RB, Ratliff NB. Evidence for rejection of homograft cardiac valves in infants. J Thorac Cardiovasc Surg. 1998;115:111–7.CrossRefPubMed
10.
go back to reference Ruel M, Chan V, Bedard P, Kulik A, Ressler L, Lam BK, Rubens FD, Goldstein W, Hendry PJ, Masters RG, Mesana TG. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116:I294–300.CrossRefPubMed Ruel M, Chan V, Bedard P, Kulik A, Ressler L, Lam BK, Rubens FD, Goldstein W, Hendry PJ, Masters RG, Mesana TG. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116:I294–300.CrossRefPubMed
11.
go back to reference Keane TJ, Swinehart IT, Badylak SF. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance. Methods. 2015;84:25–34.CrossRefPubMed Keane TJ, Swinehart IT, Badylak SF. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance. Methods. 2015;84:25–34.CrossRefPubMed
12.
go back to reference Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002–6.CrossRefPubMed Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002–6.CrossRefPubMed
13.
go back to reference Ruffer A, Purbojo A, Cicha I, Glockler M, Potapov S, Dittrich S, Cesnjevar RA. Early failure of xenogenous de-cellularised pulmonary valve conduits--a word of caution! Eur J Cardiothorac Surg. 2010;38:78–85.CrossRefPubMed Ruffer A, Purbojo A, Cicha I, Glockler M, Potapov S, Dittrich S, Cesnjevar RA. Early failure of xenogenous de-cellularised pulmonary valve conduits--a word of caution! Eur J Cardiothorac Surg. 2010;38:78–85.CrossRefPubMed
14.
go back to reference Sarikouch S, Horke A, Tudorache I, Beerbaum P, Westhoff-Bleck M, Boethig D, Repin O, Maniuc L, Ciubotaru A, Haverich A, Cebotari S. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg. 2016;50:281–90.CrossRefPubMedPubMedCentral Sarikouch S, Horke A, Tudorache I, Beerbaum P, Westhoff-Bleck M, Boethig D, Repin O, Maniuc L, Ciubotaru A, Haverich A, Cebotari S. Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience. Eur J Cardiothorac Surg. 2016;50:281–90.CrossRefPubMedPubMedCentral
15.
go back to reference Brown JW, Elkins RC, Clarke DR, Tweddell JS, Huddleston CB, Doty JR, Fehrenbacher JW, Takkenberg JJ. Performance of the CryoValve SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years. J Thorac Cardiovasc Surg. 2010;139:339–48.CrossRefPubMed Brown JW, Elkins RC, Clarke DR, Tweddell JS, Huddleston CB, Doty JR, Fehrenbacher JW, Takkenberg JJ. Performance of the CryoValve SG human decellularized pulmonary valve in 342 patients relative to the conventional CryoValve at a mean follow-up of four years. J Thorac Cardiovasc Surg. 2010;139:339–48.CrossRefPubMed
17.
go back to reference Iop L, Gerosa G. Guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials. Biomed Res Int. 2015;2015:432901.CrossRefPubMedPubMedCentral Iop L, Gerosa G. Guided tissue regeneration in heart valve replacement: from preclinical research to first-in-human trials. Biomed Res Int. 2015;2015:432901.CrossRefPubMedPubMedCentral
18.
go back to reference van Steenberghe M, Schubert T, Guiot Y, Bouzin C, Bollen X, Gianello P. Enhanced vascular biocompatibility of decellularized xeno−/allogeneic matrices in a rodent model. Cell Tissue Bank. 2017;18:249–62.CrossRefPubMed van Steenberghe M, Schubert T, Guiot Y, Bouzin C, Bollen X, Gianello P. Enhanced vascular biocompatibility of decellularized xeno−/allogeneic matrices in a rodent model. Cell Tissue Bank. 2017;18:249–62.CrossRefPubMed
19.
go back to reference van Steenberghe M, Schubert T, Xhema D, Bouzin C, Guiot Y, Duisit J, Abdelhamid K, Gianello P. Enhanced vascular regeneration with chemically/physically treated bovine/human pericardium in rodent. J Surg Res. 2018;222:167–79.CrossRefPubMed van Steenberghe M, Schubert T, Xhema D, Bouzin C, Guiot Y, Duisit J, Abdelhamid K, Gianello P. Enhanced vascular regeneration with chemically/physically treated bovine/human pericardium in rodent. J Surg Res. 2018;222:167–79.CrossRefPubMed
20.
go back to reference Cornu O, Schubert T, Libouton X, Manil O, Godts B, Van Tomme J, Banse X, Delloye C. Particle size influence in an impaction bone grafting model. Comparison of fresh-frozen and freeze-dried allografts. J Biomech. 2009;42:2238–42.CrossRefPubMed Cornu O, Schubert T, Libouton X, Manil O, Godts B, Van Tomme J, Banse X, Delloye C. Particle size influence in an impaction bone grafting model. Comparison of fresh-frozen and freeze-dried allografts. J Biomech. 2009;42:2238–42.CrossRefPubMed
21.
go back to reference Fawzi-Grancher S, Goebbels RM, Bigare E, Cornu O, Gianello P, Delloye C, Dufrane D. Human tissue allograft processing: impact on in vitro and in vivo biocompatibility. J Mater Sci Mater Med. 2009;20:1709–20.CrossRefPubMed Fawzi-Grancher S, Goebbels RM, Bigare E, Cornu O, Gianello P, Delloye C, Dufrane D. Human tissue allograft processing: impact on in vitro and in vivo biocompatibility. J Mater Sci Mater Med. 2009;20:1709–20.CrossRefPubMed
22.
go back to reference WHO. Decontamination methods for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 march 1999. In: WHO infection control guidelines for transmissible spongiform encephalopathies. WHO/CDS/CSR/APH/2000.3; 2009. p. 29–32. WHO. Decontamination methods for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 march 1999. In: WHO infection control guidelines for transmissible spongiform encephalopathies. WHO/CDS/CSR/APH/2000.3; 2009. p. 29–32.
23.
go back to reference Hulsmann J, Grun K, El Amouri S, Barth M, Hornung K, Holzfuss C, Lichtenberg A, Akhyari P. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Xenotransplantation. 2012;19:286–97.CrossRefPubMed Hulsmann J, Grun K, El Amouri S, Barth M, Hornung K, Holzfuss C, Lichtenberg A, Akhyari P. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing. Xenotransplantation. 2012;19:286–97.CrossRefPubMed
24.
go back to reference Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, Lichtenberg A, Cheptanaru E, Barnaciuc S, Cazacu A, Maliga O, Repin O, Maniuc L, Breymann T, Haverich A. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124:S115–23.CrossRefPubMed Cebotari S, Tudorache I, Ciubotaru A, Boethig D, Sarikouch S, Goerler A, Lichtenberg A, Cheptanaru E, Barnaciuc S, Cazacu A, Maliga O, Repin O, Maniuc L, Breymann T, Haverich A. Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation. 2011;124:S115–23.CrossRefPubMed
25.
go back to reference Duisit J, Orlando G, Debluts D, Maistriaux L, Xhema D, de Bisthoven YJ, Galli C, Peloso A, Behets C, Lengele B, Gianello P. Decellularization of the porcine ear generates a biocompatible, nonimmunogenic extracellular matrix platform for face subunit bioengineering. Ann Surg. 2017; Epub ahead of print Duisit J, Orlando G, Debluts D, Maistriaux L, Xhema D, de Bisthoven YJ, Galli C, Peloso A, Behets C, Lengele B, Gianello P. Decellularization of the porcine ear generates a biocompatible, nonimmunogenic extracellular matrix platform for face subunit bioengineering. Ann Surg. 2017; Epub ahead of print
26.
go back to reference Sarathchandra P, Smolenski RT, Yuen AH, Chester AH, Goldstein S, Heacox AE, Yacoub MH, Taylor PM. Impact of gamma-irradiation on extracellular matrix of porcine pulmonary valves. J Surg Res. 2012;176:376–85.CrossRefPubMed Sarathchandra P, Smolenski RT, Yuen AH, Chester AH, Goldstein S, Heacox AE, Yacoub MH, Taylor PM. Impact of gamma-irradiation on extracellular matrix of porcine pulmonary valves. J Surg Res. 2012;176:376–85.CrossRefPubMed
27.
go back to reference Theodoridis K, Muller J, Ramm R, Findeisen K, Andree B, Korossis S, Haverich A, Hilfiker A. Effects of combined cryopreservation and decellularization on the biomechanical, structural and biochemical properties of porcine pulmonary heart valves. Acta Biomater. 2016;43:71–7.CrossRefPubMed Theodoridis K, Muller J, Ramm R, Findeisen K, Andree B, Korossis S, Haverich A, Hilfiker A. Effects of combined cryopreservation and decellularization on the biomechanical, structural and biochemical properties of porcine pulmonary heart valves. Acta Biomater. 2016;43:71–7.CrossRefPubMed
28.
go back to reference Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11:457–62.PubMed Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis. 2002;11:457–62.PubMed
29.
go back to reference Pu L, Wu J, Pan X, Hou Z, Zhang J, Chen W, Na Z, Meng M, Ni H, Wang L, Li Y, Jiang L. Determining the optimal protocol for preparing an acellular scaffold of tissue engineered small-diameter blood vessels. J Biomed Mater Res B Appl Biomater. 2017; Epub ahead of print Pu L, Wu J, Pan X, Hou Z, Zhang J, Chen W, Na Z, Meng M, Ni H, Wang L, Li Y, Jiang L. Determining the optimal protocol for preparing an acellular scaffold of tissue engineered small-diameter blood vessels. J Biomed Mater Res B Appl Biomater. 2017; Epub ahead of print
30.
go back to reference Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009;5:1–13.CrossRefPubMed Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater. 2009;5:1–13.CrossRefPubMed
31.
go back to reference Wong ML, Wong JL, Vapniarsky N, Griffiths LG. In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation. Biomaterials. 2016;92:1–12.CrossRefPubMedPubMedCentral Wong ML, Wong JL, Vapniarsky N, Griffiths LG. In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation. Biomaterials. 2016;92:1–12.CrossRefPubMedPubMedCentral
32.
go back to reference Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G, Simon P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng. 2005;11:1274–80.CrossRefPubMed Kasimir MT, Rieder E, Seebacher G, Wolner E, Weigel G, Simon P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng. 2005;11:1274–80.CrossRefPubMed
33.
go back to reference Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg. 2004;127:399–405.CrossRefPubMed Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg. 2004;127:399–405.CrossRefPubMed
34.
go back to reference Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Weigel G, Simon P. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs. 2003;26:421–7.CrossRefPubMed Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner E, Weigel G, Simon P. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs. 2003;26:421–7.CrossRefPubMed
35.
go back to reference Bodnar E, Olsen EG, Florio R, Dobrin J. Damage of porcine aortic valve tissue caused by the surfactant sodiumdodecylsulphate. Thorac Cardiovasc Surg. 1986;34:82–5.CrossRefPubMed Bodnar E, Olsen EG, Florio R, Dobrin J. Damage of porcine aortic valve tissue caused by the surfactant sodiumdodecylsulphate. Thorac Cardiovasc Surg. 1986;34:82–5.CrossRefPubMed
36.
go back to reference Caamano S, Shiori A, Strauss SH, Orton EC. Does sodium dodecyl sulfate wash out of detergent-treated bovine pericardium at cytotoxic concentrations? J Heart Valve Dis. 2009;18:101–5.PubMed Caamano S, Shiori A, Strauss SH, Orton EC. Does sodium dodecyl sulfate wash out of detergent-treated bovine pericardium at cytotoxic concentrations? J Heart Valve Dis. 2009;18:101–5.PubMed
37.
go back to reference Dufrane D, Marchal C, Cornu O, Raftopoulos C, Delloye C. Clinical application of a physically and chemically processed human substitute for dura mater. J Neurosurg. 2003;98:1198–202.CrossRefPubMed Dufrane D, Marchal C, Cornu O, Raftopoulos C, Delloye C. Clinical application of a physically and chemically processed human substitute for dura mater. J Neurosurg. 2003;98:1198–202.CrossRefPubMed
38.
go back to reference Dufrane D, Mourad M, van Steenberghe M, Goebbels RM, Gianello P. Regeneration of abdominal wall musculofascial defects by a human acellular collagen matrix. Biomaterials. 2008;29:2237–48.CrossRefPubMed Dufrane D, Mourad M, van Steenberghe M, Goebbels RM, Gianello P. Regeneration of abdominal wall musculofascial defects by a human acellular collagen matrix. Biomaterials. 2008;29:2237–48.CrossRefPubMed
39.
go back to reference Navarro FB, Costa FD, Mulinari LA, Pimentel GK, Roderjan JG, Vieira ED, Noronha L, Miyague NI. Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep model. Rev Bras Cir Cardiovasc. 2010;25:377–87.CrossRefPubMed Navarro FB, Costa FD, Mulinari LA, Pimentel GK, Roderjan JG, Vieira ED, Noronha L, Miyague NI. Evaluation of the biological behavior of decellularized pulmonary homografts: an experimental sheep model. Rev Bras Cir Cardiovasc. 2010;25:377–87.CrossRefPubMed
40.
go back to reference Jorge-Herrero E, Fernandez P, de la Torre N, Escudero C, Garcia-Paez JM, Bujan J, Castillo-Olivares JL. Inhibition of the calcification of porcine valve tissue by selective lipid removal. Biomaterials. 1994;15:815–20.CrossRefPubMed Jorge-Herrero E, Fernandez P, de la Torre N, Escudero C, Garcia-Paez JM, Bujan J, Castillo-Olivares JL. Inhibition of the calcification of porcine valve tissue by selective lipid removal. Biomaterials. 1994;15:815–20.CrossRefPubMed
41.
go back to reference Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials. 2000;21:2215–31.CrossRefPubMed Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials. 2000;21:2215–31.CrossRefPubMed
42.
go back to reference Mendoza-Novelo B, Cauich-Rodriguez JV. Decellularization, stabilization and functionalization of collagenous tissues used as cardiovascular biomaterials. In: Pignatello R, editor. Biomaterials - physics and chemistry. InTech; 2011. p. 159–82. Mendoza-Novelo B, Cauich-Rodriguez JV. Decellularization, stabilization and functionalization of collagenous tissues used as cardiovascular biomaterials. In: Pignatello R, editor. Biomaterials - physics and chemistry. InTech; 2011. p. 159–82.
43.
go back to reference Lee W, Long C, Ramsoondar J, Ayares D, Cooper DK, Manji RA, Hara H. Human antibody recognition of xenogeneic antigens (NeuGc and gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? Xenotransplantation. 2016;23:370–80.CrossRefPubMed Lee W, Long C, Ramsoondar J, Ayares D, Cooper DK, Manji RA, Hara H. Human antibody recognition of xenogeneic antigens (NeuGc and gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration? Xenotransplantation. 2016;23:370–80.CrossRefPubMed
44.
go back to reference Griffiths LG, Choe LH, Reardon KF, Dow SW, Christopher OE. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials. 2008;29:3514–20.CrossRefPubMedPubMedCentral Griffiths LG, Choe LH, Reardon KF, Dow SW, Christopher OE. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials. 2008;29:3514–20.CrossRefPubMedPubMedCentral
Metadata
Title
Porcine pulmonary valve decellularization with NaOH-based vs detergent process: preliminary in vitro and in vivo assessments
Authors
Mathieu van Steenberghe
Thomas Schubert
Sébastien Gerelli
Caroline Bouzin
Yves Guiot
Daela Xhema
Xavier Bollen
Karim Abdelhamid
Pierre Gianello
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2018
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-018-0720-y

Other articles of this Issue 1/2018

Journal of Cardiothoracic Surgery 1/2018 Go to the issue